Jump to content

Search the Community

Showing results for tags 'COVID-19 pandemic'.

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type



Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Joined

  • Start

    End


Group


First name


Last name


Salutation


Country


Occupation


Organization


Website


I am joining because:

Found 15 results

  1. COVAX, the largest and most complex global distribution of vaccines is under way, protecting the most vulnerable from COVID-19, wherever they are in the world. In order to end the acute phase of the pandemic and protect the world against the spread of new variants, the global roll-out must continue at unprecedented speed. The COVAX AMC has raised US$ 9.6 billion to date. This vital funding will enable COVAX to protect almost 30% of the population in 91 lower-income economies. But the COVAX delivery schedule has been hit hard by supply delays, and faces a supply shortfall of 190 million doses. To change the course of the pandemic, plug this short-term gap and help ensure equitable access to vaccines through COVAX: o Countries that have doses need to share them now – not later, when countries’ demand and ability to absorb doses will be met by hundreds of millions of doses that will be available through COVAX Facility deals. o Manufacturers need to prioritise COVAX. o Multilateral development banks must urgently release the funds to pay for health system preparedness to ensure countries can absorb the doses delivered. We call on the international community to reaffirm its support for the COVAX AMC and act urgently as One World Protected: Committed to Deliver.
  2. A vaccine to prevent COVID-19 is likely to be the most effective way to control the pandemic. Scientists across the world have worked to develop vaccines which have then been rigorously tested for safety and efficacy. Those with a role in delivering/supporting the COVID-19 vaccine programme need to be knowledgeable, confident and competent in order to promote confidence in the vaccination programme and deliver the vaccine safely. The purpose of this pack is to ensure you have all the resources and information you need to hand, acting as a ‘go to guide’ to support you when talking with patients who are eligible for a Covid-19 vaccination but are showing signs of hesitancy. People may be concerned about or refusing the vaccine due to worries, fears, unclear about messages or for many other reasons. It’s important to understand that people will have their point of view and it may take time to talk through their concerns. Using Motivational Interviewing techniques, listening skills and sharing factual information about Covid-19 and the vaccine may help to encourage people and offer reassurance.
  3. Qui peut se faire vacciner aujourd’hui contre le Covid-19 ? Comment prendre rendez-vous pour cette vaccination ? Quels sont les effets secondaires des vaccins autorisés en France ? Comment la sécurité des vaccins est-elle garantie ? La campagne vaccinale contre le Covid-19 se poursuit et suscite toujours de nombreuses interrogations. Franceinfo s'efforce d’y répondre dans le cadre de son opération #OnVousRépond. Vous trouverez ici nos réponses aux questions les plus fréquentes sur les vaccins contre le Covid-19. Il est possible de compléter avec les sites des autorités sanitaires, les travaux des sociétés savantes (comme ce dossier de la Société de pathologie infectieuse de langue française) et bien entendu auprès de son médecin.
  4. La pandémie de Covid-19 ayant causé plus de 100 millions de cas et plus de 2,3 millions de morts à l’échelle mondiale, la publication des résultats des études pivot des premiers candidats-vaccins contre la Covid-19 a été une source d’espoir pour la communauté internationale. De nombreux pays ont rapidement initié une campagne vaccinale contre la Covid19 ; plus de 150 millions de doses ont été administrées dans le monde au 12 février 2021 (https://ourworldindata.org/covid-vaccinations). De nombreuses questions ont été soulevées en France, à la fois par les décideurs en Santé publique, mais aussi très vite par les soignants et acteurs de terrain, en charge d’informer la population, de définir et repérer les personnes prioritaires et de mettre en place la campagne vaccinale en France. Devant cette demande forte d’éclairage simple et objectif des données disponibles, la Société de Pathologie Infectieuse de Langue Française (SPILF) a été sollicitée pour élaborer un document d’information à destination des professionnels de santé.
  5. This section is an ongoing compilation of tough questions related to COVID-19, with suggested answers. Many of these topics are sensitive and often politicized. The document is designed to provide message guidance and framing for public health officials and others, and it is regularly updated to reflect new developments and emerging issues.
  6. The COVID-19 Vaccine Communications Toolkit was developed as a guide through the steps involved in planning, designing and executing a vaccine communications plan and campaign. The following information highlights the strategies and experiences of health care marketing and communications professionals and emerged from the December 2020 Society for Health Care Strategy & Market Development (SHSMD) Vaccine Distribution and Communications: A SHSMD Member Collaborative Workshop. This information will be updated as new resources, tools and examples become available.
  7. Avec TousAntiCovid, participez à la lutte contre l’épidémie en réduisant les risques de transmission.f
  8. This vaccine education PowerPoint deck is designed for use by public health officials to increase vaccine confidence in their communities. It includes areas that you can customize with local information and data. This template was requested on behalf of county and city health departments that have limited communications capacity and resources. It was published on Jan. 27, 2021, and you can make updates as vaccine development and distribution evolve.
  9. Organizations will play an important role in vaccine uptake even if they are not in the healthcare space. Employees and external audiences are increasingly depending on companies to be trusted sources for providing credible information and resources. The Institute for Public Relations (IPR) has published this in-depth guide outlining research, theories, models, levers, and research-driven recommendations to help ensure effective communication strategies for organizations worldwide.
  10. Consulte as respostas às principais perguntas e mitos, sobre a imoprtância da vacinação contra a Covid-19 e as boas práticas necessárias. No site da Sociedade Brasileira de imunizações: https://sbim.org.br/covid-19.
  11. Communication about COVID-19 vaccine safety will play a key role in maintaining the public’s confidence in vaccination. Effective communication will require planning and resources, which need to be in place as early as possible before COVID-19 vaccines are available. This module provides guidance on communicating about COVID-19 vaccine safety from a programme perspective.
  12. In recognition of the critical importance of COVID-19 vaccines and the need to understand their safety, the CONSIDER (COvid-19 vacciNe Safety questIons anD hEalthcare pRoviders) working group (WG) was created in September 2020. The CONSIDER WG aims to provide clear, comprehensive answers to questions pertaining to COVID-19 vaccine safety prior to, and during the vaccines roll out to 1) facilitate scientific discussion between stakeholders, including front line health workers with potential vaccine recipients and 2) increase comprehension and transparency of information to facilitate acceptance and uptake.
  13. In order to raise awareness among specialists and the general public about the importance of not delaying vaccination because of the new coronavirus (Sars-COV-2), SBIm - in partnership with the Brazilian Society of Pediatrics (SBP) and the Fundo das das United Nations for Children (UNICEF) - carried out the campaign “Vaccination up to date, even in the pandemic”. The initiative highlights the digital booklet "Pandemia of COVID-19: what changes in the routine of immunizations", which contains guidelines on how to maintain vaccination activities during the period and communication strategies with the population.
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. - Terms of Use - Privacy Policy - Guidelines